PHARMA-TRADE A/S: Financial statements 2018
CVR: 87339815
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMA-TRADE A/S (CVR 87339815) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,388,124 and a net result of DKK 22,465,230 compared with DKK 29,677,475 the year before. That is a decrease of 24.5% compared with the year before. Equity in the 2018 report amounted to DKK 206,553,638. The solvency ratio was 94.9%. The company had 187 employees in the financial year.
- Gross Profit
- DKK 1,388,124
- Profit/Loss
- DKK 22,465,230
- Equity
- DKK 206,553,638
- Total Assets
- DKK 217,618,846
- Employees
- 187
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.4 mio. | 22.5 mio. | 206.6 mio. | 187 |
| 2017 | - | 1.8 mio. | 29.7 mio. | 208.5 mio. | 178 |
| 2016 | - | 2.1 mio. | 33.7 mio. | 202.1 mio. | 179 |
| 2015 | - | 1.8 mio. | 27.8 mio. | 184.5 mio. | 169 |
| 2014 | - | 1.5 mio. | 26.4 mio. | 153.6 mio. | 164 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PHARMA-TRADE A/S has published its annual report for 2017. Gross profit came to DKK 1,839,240, and the net result was DKK 29,677,475.
About PHARMA-TRADE A/S
PHARMA-TRADE A/S is a Danish company of the type Aktieselskab based in Græsted, founded in 1984. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named PHARMATRADE A/S and FATIMA A/S. The management consists of Henrik Overgaard. The board consists of Jan Overgaard (chair), Henrik Overgaard and Kresten Mikael Valdal. The company is owned by PIF Holding ApS and DANYL FINANS A/S. The company has 3 employees (2019). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 21,231,368 compared with DKK 43,142,185 the year before. Equity in the 2025 report amounted to DKK 254,017,471.